1. SNHG3 promotes proliferation and invasion by regulating the miR-101/ZEB1 axis in breast cancer
    Liang Chang et al, 2018, RSC Adv. CrossRef
  2. MiR-320d suppresses the progression of breast cancer via lncRNA HNF1A-AS1 regulation and SOX4 inhibition.
    Shuai Shi et al, 2018, RSC Adv CrossRef
  3. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1
    Li-Qing Wei et al, 2018, J Cell Physiol CrossRef
  4. Long Non-Coding RNA and Breast Cancer
    Tianzhu Zhang et al, 2019, Technol Cancer Res Treat CrossRef
  5. The pseudogene PTENP1 regulates smooth muscle cells as a competing endogenous RNA
    Yanxian Lai et al, 2019, Clin. Sci. CrossRef
  6. Expression of gastrin in colon cancer and its effect on human colon cancer cell proliferation and P38 signal transduction pathway
    Bin-Feng Wang et al, 2019, WCJD CrossRef
  7. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.
    Qingli Kong et al, 2018, Biochem Biophys Res Commun CrossRef
  8. The Mechanisms Underlying PTEN Loss in Human Tumors Suggest Potential Therapeutic Opportunities.
    Hyeyoun Chang et al, 2019, Biomolecules CrossRef
  9. Exosome-derived PTENP1 suppresses cisplatin resistance of bladder cancer (BC) by suppressing cell proliferation, migration and inducing apoptosis via the miR-103a/PDCD4 axis
    Xingre Lu et al, 2019, RSC Adv. CrossRef
  10. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
    Kai Fang et al, 2020, Carcinogenesis CrossRef
  11. Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer.
    Weiyang Lou et al, 2020, Front Cell Dev Biol CrossRef
  12. Roles of lncRNAs in cancer: Focusing on angiogenesis
    Ke-Tao Jin et al, 2020, Life Sciences CrossRef
  13. Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
    John Kerwin et al, 2020 CrossRef
  14. Elevation of FGD5-AS1 contributes to cell progression by improving cisplatin resistance against non-small cell lung cancer cells through regulating miR-140-5p/WEE1 axis.
    Jun Fu et al, 2020, Gene CrossRef
  15. Interaction of long-chain non-coding RNAs and important signaling pathways on human cancers (Review)
    Wei Sun et al, 2018, Int J Oncol CrossRef
  16. HAUBRW: Hybrid algorithm and unbalanced bi-random walk for predicting lncRNA-disease associations
    Guobo Xie et al, 2020, Genomics CrossRef
  17. Down-regulation of lncRNA UCA1 enhances radiosensitivity in prostate cancer by suppressing EIF4G1 expression via sponging miR-331-3p
    Minhua Hu et al, 2020, Cancer Cell Int CrossRef
  18. Role and the molecular mechanism of lncRNA PTENP1 in regulating the proliferation and invasion of cervical cancer cells
    Chengping Wu et al, 2020, Gene Ther CrossRef
  19. Thioridazine hydrochloride: an antipsychotic agent that inhibits tumor growth and lung metastasis in triple-negative breast cancer via inducing G0/G1 arrest and apoptosis
    Yanlin Song et al, 2020, Cell Cycle CrossRef
  20. DSCMF: prediction of LncRNA-disease associations based on dual sparse collaborative matrix factorization
    Jin-Xing Liu et al, 2021, BMC Bioinformatics CrossRef
  21. Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects
    Xinrong Lin et al, 2021, Front. Oncol. CrossRef
  22. Long Non-Coding RNAs as Potential Diagnostic and Prognostic Biomarkers in Breast Cancer: Progress and Prospects.
    Cuicui Lu et al, 2021, Front Oncol CrossRef
  23. What is beyond LncRNAs in breast cancer: A special focus on colon cancer-associated Transcript-1 (CCAT-1)
    Noha A. Selem et al, 2021, Non-coding RNA Research CrossRef
  24. null
    Yuan-Shan Zhu et al, 2022 CrossRef
  25. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer.
    Rasoul Abdollahzadeh et al, 2019, J Cell Physiol CrossRef
  26. A review on the role of PTENP1 in human disorders with an especial focus on tumor suppressor role of this lncRNA
    Soudeh Ghafouri-Fard et al, 2022, Cancer Cell Int CrossRef
  27. Epigenetic factors in breast cancer therapy
    Runjhun Mathur et al, 2022, Front. Genet. CrossRef
  28. Variant of SNP rs1317082 at CCSlnc362 (RP11-362K14.5) creates a binding site for miR-4658 and diminishes the susceptibility to CRC
    Chaoqin Shen et al, 2018, Cell Death Dis CrossRef
  29. Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis
    Amir Sadra Zangouei et al, 2023, Biol Res CrossRef
  30. Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance
    Dharambir Kashyap et al, 2023, Front. Genet. CrossRef
  31. BRWMC: Predicting lncRNA-disease associations based on bi-random walk and matrix completion on disease and lncRNA networks
    Guo-Zheng Zhang et al, 2023, Computational Biology and Chemistry CrossRef
  32. Expression analysis of novel long non-coding RNAs for invasive ductal and invasive lobular breast carcinoma cases
    Çağdaş Aktan et al, 2023, Pathology - Research and Practice CrossRef
  33. LncRNA PVT1: as a therapeutic target for breast cancer
    Kamilya Jamel Baljon et al, 2023, Pathology - Research and Practice CrossRef
  34. Long non-coding RNAs as the critical regulators of PI3K/AKT, TGF-β, and MAPK signaling pathways during breast tumor progression
    Amirhosein Maharati et al, 2023, J Transl Med CrossRef